Insufficient scRNA-seq data for expression of ZNG1C at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 226.06 | 458 / 459 | 14% | 0.23 | 156 / 1118 |
esophagus | 99% | 107.29 | 1428 / 1445 | 12% | 0.16 | 22 / 183 |
bladder | 100% | 158.14 | 21 / 21 | 5% | 0.07 | 27 / 504 |
brain | 99% | 194.06 | 2609 / 2642 | 4% | 0.05 | 26 / 705 |
ovary | 100% | 91.86 | 180 / 180 | 1% | 0.01 | 3 / 430 |
uterus | 100% | 88.04 | 170 / 170 | 0% | 0.01 | 2 / 459 |
spleen | 100% | 172.24 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 100% | 137.02 | 653 / 653 | 0% | 0 | 0 / 605 |
lung | 98% | 79.44 | 569 / 578 | 1% | 0.02 | 17 / 1155 |
prostate | 100% | 159.33 | 244 / 245 | 0% | 0 | 0 / 502 |
skin | 100% | 174.53 | 1800 / 1809 | 0% | 0 | 0 / 472 |
intestine | 99% | 96.31 | 959 / 966 | 0% | 0.01 | 1 / 527 |
adipose | 98% | 78.56 | 1183 / 1204 | 0% | 0 | 0 / 0 |
kidney | 98% | 70.45 | 87 / 89 | 0% | 0.01 | 3 / 901 |
liver | 97% | 73.32 | 220 / 226 | 0% | 0 | 0 / 406 |
pancreas | 97% | 72.86 | 317 / 328 | 1% | 0.01 | 1 / 178 |
blood vessel | 97% | 69.01 | 1296 / 1335 | 0% | 0 | 0 / 0 |
stomach | 94% | 58.25 | 339 / 359 | 1% | 0.04 | 3 / 286 |
adrenal gland | 94% | 52.77 | 243 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 84% | 103.21 | 776 / 929 | 0% | 0 | 0 / 0 |
heart | 73% | 33.86 | 626 / 861 | 0% | 0 | 0 / 0 |
muscle | 52% | 20.52 | 415 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005525 | Molecular function | GTP binding |
GO_0016787 | Molecular function | hydrolase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNG1C |
Protein name | Zn regulated GTPase metalloprotein activator 1C (Zn regulated GTPase metalloprotein activator 1E) Zn regulated GTPase metalloprotein activator 1C Zinc-regulated GTPase metalloprotein activator 1C (EC 3.6.5.-) (Cobalamin synthase W domain-containing protein 3) (COBW domain-containing protein 3) Zn regulated GTPase metalloprotein activator 1C (Zn regulated GTPase metalloprotein activator 1E) (Zn regulated GTPase metalloprotein activator 1F) |
Synonyms | CBWD3 ZNG1F ZNG1E |
Description | FUNCTION: Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them. Catalyzes zinc insertion into the active site of methionine aminopeptidase METAP1, which function to cleave the initiator methionine from polypeptides during or after protein translation. Mechanistically, the N-terminal psi-PxLVp motif binds to the C6H2-type zinc finger of inactive form of METAP1. After formation of the docked complex, zinc is transferred from the CXCC motif in the GTPase domain of ZNG1C to the zinc binding site in the peptidase domain of METAP1 in a process requiring GTP hydrolysis. GTP/GDP exchange is required for release of active METAP1. . |
Accessions | ENST00000613716.5 Q5JTY5 A0A087WYD2 ENST00000615061.4 ENST00000618217.4 ENST00000465474.5 A0A087WWG3 A0A0A0MRU4 ENST00000377389.5 ENST00000360171.11 [Q5JTY5-1] ENST00000622755.4 F2Z3P0 ENST00000377349.6 ENST00000469921.5 ENST00000612050.4 ENST00000377342.9 Q5RIB5 ENST00000377384.5 ENST00000611426.4 ENST00000478048.5 |